Tag results:
myeloid cells
Mammary Cell News
Trastuzumab/Pertuzumab Combination Therapy Stimulates Anti-tumor Responses through Complement-Dependent Cytotoxicity and Phagocytosis
[JCI Insight] Investigators identified that only Trastuzumab+Pertuzumab combination therapy, but not when either antibody used in isolation, allowed for the activation of the classical complement pathway, resulting in both direct complement-dependent cytotoxicity as well as complement-dependent cellular phagocytosis of HER2+ breast cancer cells.
ESC & iPSC News
Mapping the Biogenesis of Forward Programmed Megakaryocytes from Induced Pluripotent Stem Cells
[Science Advances] Investigators developed a system for the production of platelet precursor cells, megakaryocytes, from PSCs. These cultures could be maintained for greater than 100 days, implying culture renewal by megakaryocyte progenitors.
Hepatic Cell News
PD-L1 Blockade Liberates Intrinsic Antitumourigenic Properties of Glycolytic Macrophages in Hepatocellular Carcinoma
[Gut] Scientists elucidated the nature, regulation and functional relevance of PD-L1+ host cells in HCC.
Cell Therapy News
Increased Visceral Fat Distribution and Body Composition Impact Cytokine Release Syndrome Onset and Severity after CD19 CAR-T in Advanced B Cell Malignancies
[Haematologica] Researchers studied the influence of anthropometric and body composition measurements on CAR-T-related immunotoxicity in 64 patients receiving CD19-directed CAR-T for relapsed/refractory B cell malignancies.
Human Immunology News
Neutrophil-Derived Extracellular Vesicles Promote Feed-Forward Inflammasome Signaling in Cystic Fibrosis Airways
[Journal of Leukocyte Biology] Researchers hypothesized that cystic fibrosis airway neutrophils contributed to chronic inflammation, in part, via the packaging of inflammasome-inducing signals in extracellular vesicles.
Neural Cell News
Dual-sgRNA CRISPR/Cas9 Knockout of PD-L1 in Human U87 Glioblastoma Tumor Cells Inhibits Proliferation, Invasion, and Tumor-Associated Macrophage Polarization
[Scientific Reports] Utilizing dual-single guide RNAs (sgRNAs) and a homology-directed repair template with the CRISPR/Cas9 gene-editing system is a promising avenue for the treatment of glioblastoma multiforme.